| Symbol |
Name |
|
AFF1
|
AF4/FMR2 family, member 1
|
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2
|
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
BAIAP3
|
BAI1-associated protein 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BMP2K
|
BMP2 inducible kinase
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCND2
|
cyclin D2
|
|
CCNT1
|
cyclin T1
|
|
CCNT2
|
cyclin T2
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD86
|
CD86 molecule
|
|
CDK14
|
cyclin-dependent kinase 14
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDPF1
|
cysteine-rich, DPF motif domain containing 1
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
COMMD3-BMI1
|
COMMD3-BMI1 readthrough
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
DAND5
|
DAN domain family member 5, BMP antagonist
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA1B
|
defensin, alpha 1B
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEFA4
|
defensin, alpha 4, corticostatin
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFA6
|
defensin, alpha 6, Paneth cell-specific
|
|
DOT1L
|
DOT1-like histone H3K79 methyltransferase
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELK4
|
ELK4, ETS-domain protein (SRF accessory protein 1)
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ETV1
|
ets variant 1
|
|
ETV4
|
ets variant 4
|
|
ETV5
|
ets variant 5
|
|
ETV6
|
ets variant 6
|
|
ETV7
|
ets variant 7
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FEV
|
FEV (ETS oncogene family)
|
|
FLII
|
flightless I homolog (Drosophila)
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOXO1
|
forkhead box O1
|
|
FUS
|
FUS RNA binding protein
|
|
FUT8
|
fucosyltransferase 8 (alpha (1,6) fucosyltransferase)
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H3-3A
|
H3.3 histone A
|
|
H3-3B
|
H3.3 histone B
|
|
H3-4
|
H3.4 histone, cluster member
|
|
H3-5
|
H3.5 histone
|
|
H3-7
|
H3.7 histone (putative)
|
|
H3C13
|
H3 clustered histone 13
|
|
H3C7
|
H3 clustered histone 7
|
|
H3Y2
|
H3.Y histone 2
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HOXA10
|
homeobox A10
|
|
HOXA11
|
homeobox A11
|
|
HOXA9
|
homeobox A9
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL3
|
interleukin 3
|
|
IL6
|
interleukin 6
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB7
|
integrin, beta 7
|
|
JMJD1C
|
jumonji domain containing 1C
|
|
JUP
|
junction plakoglobin
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KLF3
|
Kruppel-like factor 3 (basic)
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
LDB2
|
LIM domain binding 2
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LOC102724971
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAX
|
MYC associated factor X
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEIS1
|
Meis homeobox 1
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NDUFA2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NGFR
|
nerve growth factor receptor
|
|
NR4A1AS
|
NR4A1 antisense RNA
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NSD2
|
nuclear receptor binding SET domain protein 2
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUPR1
|
nuclear protein, transcriptional regulator, 1
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX7
|
paired box 7
|
|
PAX8
|
paired box 8
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PBX3
|
pre-B-cell leukemia homeobox 3
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PER2
|
period circadian clock 2
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PML
|
promyelocytic leukemia
|
|
POLK
|
polymerase (DNA directed) kappa
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRCC
|
papillary renal cell carcinoma (translocation-associated)
|
|
PROM1
|
prominin 1
|
|
PTCRA
|
pre T-cell antigen receptor alpha
|
|
PTK2
|
protein tyrosine kinase 2
|
|
RARA
|
retinoic acid receptor, alpha
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RXRB
|
retinoid X receptor, beta
|
|
RXRG
|
retinoid X receptor, gamma
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIX1
|
SIX homeobox 1
|
|
SIX4
|
SIX homeobox 4
|
|
SLC45A3
|
solute carrier family 45, member 3
|
|
SLTM
|
SAFB-like, transcription modulator
|
|
SMAD1
|
SMAD family member 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SS18L1
|
synovial sarcoma translocation gene on chromosome 18-like 1
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
SSX2B
|
synovial sarcoma, X breakpoint 2B
|
|
SSX3
|
synovial sarcoma, X breakpoint 3
|
|
SSX4
|
synovial sarcoma, X breakpoint 4
|
|
SSX4B
|
synovial sarcoma, X breakpoint 4B
|
|
SSX5
|
synovial sarcoma, X breakpoint 5
|
|
SSX7
|
synovial sarcoma, X breakpoint 7
|
|
SUPT3H
|
suppressor of Ty 3 homolog (S. cerevisiae)
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TCF3
|
transcription factor 3
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TLX3
|
T-cell leukemia homeobox 3
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TP53
|
tumor protein p53
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TSPAN7
|
tetraspanin 7
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
WT1
|
Wilms tumor 1
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
